Vico Therapeutics has started patient dosing in an expanded cohort under a twice-yearly regimen for its Phase I/IIa clinical ...
On Monday, Verisk Analytics Inc. VRSK said it has entered into accelerated share repurchase agreements to buy back $1.5 billion of its common stock. The move follows last week's board approval to ...
EquipmentShare.com Inc. (NASDAQ:EQPT) is among the 11 Newly-Listed NASDAQ Stocks to Buy Now. On February 17, 2026, UBS ...
UniQure (NASDAQ:QURE) is one of the top gene therapy stocks to buy according to hedge funds. Wolfe Research initiated coverage of UniQure (NASDAQ:QURE) with a Peer Perform rating on February 23, ...
Barclays analyst Glen Santangelo initiated coverage of Cardinal Health, Inc. (NYSE:CAH) on December 9, giving the stock an Overweight rating and a $243 price target. The firm started its broader view ...
On February 5, Benchmark analyst Benjamin Klieve initiated coverage of The Andersons, Inc. (NASDAQ:ANDE) with a Buy rating and a $75 price target. He pointed to growing momentum in the company’s ...
AUSTIN, Texas, Feb. 25, 2026 (GLOBE NEWSWIRE) -- via IBN - Frontieras North America Inc., an energy and environmental ...
On Feb. 12, 2026, the New York State Public Service Commission (PSC) initiated a new proceeding (Case 26-E-0045) to reform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results